1 asset in Progressive Familial Intrahepatic Cholestasis
Therapeutic assets addressing Progressive Familial Intrahepatic Cholestasis, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Maralixibat Progressive Familial Intrahepatic Cholestasis | Mirum Pharmaceuticals, Inc. | P2 | B (62) |